Differences in HIV Natural History among African and Non-African Seroconverters in Europe and Seroconverters in Sub-Saharan Africa

• Nikos Pantazis ,

  * E-mail: npantaz@med.uoa.gr

  Affiliation Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School, Athens, Greece

  ⨯
• Charles Morrison,

  Affiliation FHI 360, Durham, North Carolina, United States of America

  ⨯
• Pauli N. Amornkul,

  Affiliation International AIDS Vaccine Initiative (IAVI), San Francisco, California, United States of America

  ⨯
• Charlotte Lewden,

  Affiliations Université Victor Segalen Bordeaux 2, ISPED, Bordeaux, France, Inserm, U897, Bordeaux, France

  ⨯
• Robert A. Salata,

  Affiliation Case Western Reserve University, Cleveland, Ohio, United States of America

  ⨯
• Albert Minga,

  Affiliation Programme PAC-CI, Abidjan, Côte d'Ivoire

  ⨯
• Tsungai Chipato,

  Affiliation University of Zimbabwe, Harare, Zimbabwe

  ⨯
• Harold Jaffe,

  Affiliation University of Oxford, Oxford, United Kingdom

  ⨯
• Shabir Lakhi,

  Affiliation Zambia Emory HIV Research Project (ZEHRP), Lusaka, Zambia

  ⨯
• Etienne Karita,

  Affiliation Project San Francisco, Kigali, Rwanda

  ⨯
• Kholoud Porter,

  Affiliation Medical Research Council Clinical Trials Unit, London, United Kingdom

  ⨯
• Laurence Meyer,

  Affiliation Inserm, U1018, HIV Epidemiology, Université Paris-Sud, AP-HP, Le Kremlin-Bicêtre, France

  ⨯
• Giota Touloumi,

  Affiliation Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School, Athens, Greece

  ⨯
• on behalf of CASCADE Collaboration in EuroCoord and ANRS 1220 Primo-CI Study Group

  ¶Membership of the CASCADE Collaboration in EuroCoord and ANRS 1220 Primo-CI Study Group is provided in the Acknowledgments.

  ⨯